Skip to content

CRISPR Therapeutics

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2026

    CRISPR Therapeutics reports quarterly earnings

    CRISPR Therapeutics reported quarterly earnings data, including EPS of ($1.15), missing the consensus estimate of ($1.04) by $0.11, and revenue of $12.67 million.